IL-6 (Interleukin-6)
Interleukin-6 (IL-6) is a versatile cytokine. It is made by immune cells, fat cells, blood-vessel cells, and senescent cells. It signals two ways: through a membrane-bound receptor (classical signaling) or a soluble one (trans-signaling), with different effects in different tissues. In short bursts, IL-6 is useful. It drives your liver's acute-phase response (raising CRP, fibrinogen, and serum amyloid A) and is essential for fighting infection. After hard exercise, your muscles release a lot of it briefly, acting as a 'myokine'. The problem is chronic elevation. Steady high IL-6, as in chronic inflammation, obesity, and aging (inflammaging), independently predicts death from all causes and from heart disease across many large studies. That prediction holds even after accounting for CRP. In longevity research, IL-6 is a central marker of inflammaging and a drug target under study, since high IL-6 feeds pathways tied to muscle loss, cognitive decline, frailty, and cancer.
Last reviewed:
This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer
Sources
- Interleukin-6 Receptor Mendelian Randomisation Analysis Consortium. (2012). The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. *Lancet*doi:10.1016/S0140-6736(12)60110-X
- Hunter CA, Jones SA. (2015). IL-6 as a keystone cytokine in health and disease. *Nature Immunology*doi:10.1038/ni.3153
- Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, et al.. (2001). Cardiovascular disease, interleukin-6, and risk of mortality in older women: the Women's Health and Aging Study. *Circulation*doi:10.1161/01.CIR.103.7.947
